US 6,335,013 B1 · Methods and materials relating to CD39-like polypeptides

Abstract

The invention provides novel polynucleotides isolated from cDNA libraries of human fetal liver-spleen and macrophage as well as polypeptides encoded by these polynucleotides and mutants or variants thereof. The polypeptides correspond to a novel human CD39-like protein. Other aspects of the invention include vectors containing polynucleotides of the invention and related host cells as well a processes for producing novel CD39-like polypeptides, and antibodies specific for such polypeptides.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/608,285Filed 30 Jun 2000

Granted

1 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07K 14/70596
Receptors; Cell surface antigens; Cell surface determinants: molecules with a "CD"-designation not provided for elsewhere
C12N 9/14
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes: hydrolases
C12Q 1/6883
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes: for diseases caused by alterations of genetic material
A01K 2217/05
Genetically modified animals: animals comprising random inserted nucleic acids

Methods and materials relating to CD39-like polypeptides

Life of this patent

Abstract

Claims0

Methods and materials relating to CD39-like polypeptides

Life of this patent

Abstract

Claims0